Allergan, Inc.
U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany
New Jersey
07054
United States
Tel: 1 (862) 261-7000
Website: http://www.allergan.com/
About Allergan, Inc.
Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.
We’re Looking for the World’s Best
At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.
At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.
Commit to your future and join us. Learn more about our exciting career opportunities at www.allergan.com/careers.
YEAR FOUNDED:
1948
LEADERSHIP:
Founder: Gavin S. Herbert
CEO: Brenton L. Saunders
CFO: Maria Teresa Hilado
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products
1188 articles about Allergan, Inc.
-
Actavis Agrees To Buy Allergan For $66 Billion
11/18/2014
-
Physicians Continue To Voice Strong Support For Allergan Inc. Via Open Letters To The Eye Care Community
11/14/2014
-
Actavis In Talks To Buy Allergan Inc. For Over $60 Billion
11/14/2014
-
Allergan Inc. Board Of Directors Announces Approval Of Amendments To Company’s Bylaws
11/12/2014
-
Allergan Inc. Release: New Survey Reveals What Women In The U.S. Really Want To Know About BOTOX® Cosmetic (onabotulinumtoxina)
11/11/2014
-
Salix Pharmaceuticals, Ltd. Plummets As Accounting Scandal Sinks Deal With Allergan Inc., CFO Resigns
11/10/2014
-
Allergan Inc. Tussle Plumps Up Botox Maker’s Price
11/7/2014
-
Allergan Inc. Release: New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1)
11/6/2014
-
Allergan Inc. Confirms Second Suitor Wants To Buy It, Is It Actavis?
11/5/2014
-
Allergan Inc. Comments On California Federal Court Ruling In Insider Trading Lawsuit Against Valeant & Pershing Square
11/5/2014
-
Valeant: We Will Bump Allergan Inc. Offer To $200 A Share
10/28/2014
-
Valeant Delivers Letter To Allergan Inc. Board
10/28/2014
-
Allergan Inc. Comments On Valeant Letter
10/27/2014
-
Allergan Inc. Announces Quarterly Conference Call
10/27/2014
-
Valeant Hints At Higher Bid For Allergan Inc.
10/21/2014
-
Allergan Inc. Chops Jobs In Carlsbad
10/21/2014
-
Lawyers Have Documents That Prove Allergan Inc. Misled Investors About Valeant: Ackman
10/17/2014
-
Fidelity Ups Its Stake In Allergan Inc. As Actavis Bid Rumors Fly; Potential $60 Billion Deal
10/10/2014
-
Valeant Will Sweeten Allergan Inc. Bid To Clinch Deal
10/9/2014
-
Allergan Inc. Provides Update On Earnings Per Share And Sales Expectations
10/9/2014